logo

Context Therapeutics Inc (CNTX) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Context Therapeutics Inc’s current trading price is -14.20% away from its 52-week high, while its distance from the 52-week low is 208.51%. The stock’s price range for this time frame has been between $0.47 and $1.69. The trading volume of the company’s shares in the Healthcare reached around 23.33 million for the day, which was evidently higher than the average daily volume of 57030.0 over the last three months.

Context Therapeutics Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $1.69 on 05/02/24, and the lowest price during that time was $0.47, recorded on 05/15/23.

How Financial Performance Impacts Market Capitalization

Context Therapeutics Inc (CNTX) has experienced a quarterly rise of 40.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 23.16M and boasts a workforce of 5 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1668, with a change in price of +0.6862. Similarly, Context Therapeutics Inc recorded 284,312 in trading volume during the last 100 days, posting a change of +80.26%.

How CNTX’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CNTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

CNTX Stock Stochastic Average

Context Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 62.43%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 47.76%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 37.94% and 37.24%, respectively.

CNTX Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a gain of 28.32%.However, over the last six months, we can see a weaker performance of 36.79%. Over the last 30 days, the price of CNTX has fallen by 16.94%. And in the last five days, it has surged by 5.07%.

Most Popular